CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, Operations sold 20,132 shares at $1.27 ($25,568)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.40 ($14,000)
- 4 Open-market buy Director bought 100,000 shares at $1.91 ($191,000)
- 4 Open-market buy Director bought 23,770 shares at $1.76 ($41,835)
- 4 Open-market buy Director bought 50,000 shares at $1.83 ($91,500)
- 4 Open-market buy Director bought 75,000 shares at $1.73 ($129,750)
- 4 Open-market buy Director bought 100,000 shares at $1.71 ($171,000)
- 4 Grant or award Chief Executive Officer acquired 875,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 80,645 shares (grant or award)
- 4 Grant or award Director acquired 4,167 shares (grant or award)
- 4 Grant or award Director acquired 4,167 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
Page 5 of 24 · 465 filings